Pay in 4 interest-free payments of $6.23 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
In the Phase 2 clinical trial published in the New England Journal of Medicine (2023), participants receiving retatrutide achieved mean weight reductions of up to approximately 24% over 48 weeks
Clinical studies have shown significant weight loss outcomes
Tirzepatide has no clear link to causing irregular heartbeats
In addition to this, its unclear whether insurance companies will begin adopting generic semaglutide in Canada as a covered treatment
March 25, 2024 Glucagon-like peptide-1 (GLP-1) drugs for diabetes and weight loss represent the new wave of blockbuster drugs
Weight loss plateau on tirzepatide Plateaus happen with every weight loss medication
US$ 28.74
US$ 22.07
US$ 26.20
US$ 26.06
US$ 24.55
US$ 26.65
US$ 21.90
